Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rat nerve growth factor for children with cerebral palsy and global developmental delay
ChiCTR2000032283Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of rat nerve growth factor in cerebral palsy (CP) and Global Developmental Delay (GDD) (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Gesell developmental diagnostic scale, Infant - junior high school students social life ability scale and 1 more. Started May 2020; status: recruiting.
02
Drugs
rat nerve growth factor
03
Conditions
cerebral palsy (CP)Global Developmental Delay (GDD)
Beyond the preview
Go deeper on ChiCTR2000032283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032283.